{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T09:56:12Z","timestamp":1694944572156},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/med.0b013e328363184d","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T11:18:39Z","timestamp":1372245519000},"page":"314-320","source":"Crossref","is-referenced-by-count":7,"title":["Updates in growth hormone treatment and mortality"],"prefix":"10.1097","volume":"20","author":[{"given":"Mark","family":"Sherlock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ecl.2007.10.004","article-title":"Hypopituitarism: clinical features, diagnosis, and management.","volume":"37","author":"Toogood","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-10-20211004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease.","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"R4-10-20211004","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma.","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"R5-10-20211004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma.","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-10-20211004","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","article-title":"Cerebrovascular mortality in patients with pituitary adenoma.","volume":"57","author":"Brada","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R7-10-20211004","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM198511143132005","article-title":"The autopsy as a measure of accuracy of the death certificate.","volume":"313","author":"Kircher","year":"1985","journal-title":"N Engl J Med"},{"key":"R8-10-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01600228","article-title":"The accuracy of death certificates. Implications for health statistics.","volume":"419","author":"Nielsen","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R9-10-20211004","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.smj.0000224337.77074.57","article-title":"Death certificates are not reliable: revivification of the autopsy.","volume":"99","author":"Ravakhah","year":"2006","journal-title":"South Med J"},{"key":"R10-10-20211004","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0046-8177(98)90018-1","article-title":"The necessary role of the autopsy in cardiovascular epidemiology.","volume":"29","author":"Smith","year":"1998","journal-title":"Hum Pathol"},{"key":"R11-10-20211004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.1999.00650.x","article-title":"Life expectancy following surgery for pituitary tumours.","volume":"50","author":"Bates","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-10-20211004","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-10-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism.","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R14-10-20211004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","article-title":"Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.","volume":"10","author":"Nielsen","year":"2007","journal-title":"Pituitary"},{"key":"R15-10-20211004","first-page":"1420","article-title":"Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.","volume":"85","author":"Nilsson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-10-20211004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"R17-10-20211004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study.","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R18-10-20211004","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-10-20211004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"R20-10-20211004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.2007.02947.x","article-title":"Excess mortality in women with pituitary disease: a meta-analysis.","volume":"67","author":"Nielsen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R21-10-20211004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/eje.0.1500149","article-title":"Direct causes of death in Japanese patients with hypopituitarism as analyzed from a nation-wide autopsy database.","volume":"150","author":"Kaji","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R22-10-20211004","first-page":"229","article-title":"CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency.","volume":"60","author":"Lonn","year":"1993","journal-title":"Basic Life Sci"},{"key":"R23-10-20211004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.1.02179","article-title":"Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults: a KIMS database analysis.","volume":"155","author":"Abs","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R24-10-20211004","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-10-20211004","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"R26-10-20211004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.1.01817","article-title":"One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.","volume":"152","author":"Boguszewski","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R27-10-20211004","first-page":"1874","article-title":"Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.","volume":"86","author":"Colao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-10-20211004","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"key":"R29-10-20211004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men.","volume":"43","author":"de BH, Blok","year":"1994","journal-title":"Metabolism"},{"key":"R30-10-20211004","first-page":"58","article-title":"Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.","volume":"84","author":"Serri","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-10-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"R32-10-20211004","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-10-20211004","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1210\/jcem.87.7.8655","article-title":"Peripheral vascular structure and function in men with contrasting GH levels.","volume":"87","author":"Irving","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-10-20211004","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-10-20211004","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-10-20211004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.2000.01108.x","article-title":"Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.","volume":"53","author":"Florakis","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R37-10-20211004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.13.2.296","article-title":"Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.","volume":"13","author":"Eden","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"Pt 4","key":"R38-10-20211004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/000456329603300408","article-title":"Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.","volume":"33","author":"OHalloran","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"R39-10-20211004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1054\/ghir.2000.0172","article-title":"Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults.","volume":"10","author":"Wieringa","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"R40-10-20211004","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jcem.84.11.6171-1","article-title":"Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group.","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-10-20211004","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency Data from the Dutch National Registry of Growth Hormone Treatment in adults.","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-10-20211004","first-page":"380","article-title":"Reports of increased mortality and GH: will this affect current clinical practice J Clin Endocrinol M","volume":"97","author":"Malozowski","year":"2012","journal-title":"etab"},{"key":"R43-10-20211004","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults.","volume":"341","author":"Takala","year":"1999","journal-title":"N Engl J Med"},{"key":"R44-10-20211004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement.","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R45-10-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of cancer in patients treated with human pituitary growth hormone in the UK 1959-1985 a cohort study.","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"R46-10-20211004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children.","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-10-20211004","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.","volume":"97","author":"Savendahl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-10-20211004","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-10-20211004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R50-10-20211004","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addisons disease: a population-based study.","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-10-20211004","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-10-20211004","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201308000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:35:24Z","timestamp":1633509324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201308000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328363184d","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}